The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and...
Brooks Rehabilitation first participant in the national stroke recovery trial, EMAGINE, has just completed study participation. The randomized, double-blind study tests whether a non-invasive,...
Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of inflammatory disorders and autoimmune diseases, today announced...
Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, announced the first implantation of...
Guerbet (FR0000032526 GBT), a global leader in medical imaging, announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol),...
